News Tag: Newsletter

Cancer Survivorship Month: Honoring the Resilience of All Affected by Cancer

Read More

FORTE Study Updates: February 2025 Newsletter

Read More

NRG Opens First Pragmatic and Streamlined Trial: One Versus Two Years of Maintenance Olaparib for Patients with BRCA1/2 Mutated or Homologous Recombination Deficient (HRD+) Ovarian Cancer (NRG-GY036)

Read More

February is Cancer Prevention Month: Steps We Can Take Today for a Healthier Tomorrow

Read More

FORTE Study Updates – January 2025 Newsletter

Read More

From Fear to Advocacy: Kimberly Williams’ Journey as a Cervivor Change Agent

Read More

FORTE Study Update: December 2024 Newsletter

Read More

Testing Proton Craniospinal Radiation Therapy for Patients with Breast or Non-Small Cell Lung Cancer Leptomeningeal Metastasis (NRG-BN014)

Read More

Making the Best of the Worst: The Importance of Having a Positive Healthcare Team

Read More